Emodepside Phase II Trial for Treatment of Onchocerciasis
Status:
Recruiting
Trial end date:
2026-10-02
Target enrollment:
Participant gender:
Summary
The trial evaluates safety, tolerability, pharmacodynamics, pharmacokinetics, dose-response,
and efficacy of emodepside tablets, administrated as a range of dose regimens, in adults
infected with Onchocerca Volvulus.